BullFrog AI Holdings
  • Home
  • About
  • Our Technology
  • Our Solution
  • News/Press
  • Contact
  • Invest

News and Press

May 21, 2020

BullFrog AI and TTi Health Research & Economics Announce Partnership

BullFrog AI, Inc., a precision pharmaceutical company built around a powerful artificial intelligence (AI) platform, proudly announces its newest partnership with TTi Health Research & Economics. TTi Health Research & Economics will…

Continue Reading
May 7, 2020

BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development

Partnership Helps Tackle Pharmaceutical’s Real-World Challenges in Search for Vaccines and Medication BullFrog AI, Inc., a precision pharmaceutical company built around a powerful artificial intelligence (AI) platform, proudly announces its…

Continue Reading
April 7, 2020

BullFrog AI Secures $200K from TEDCO’s Seed Fund

BullFrog AI, Inc, a precision pharmaceutical company built around a powerful artificial intelligence (AI) platform, proudly announces TEDCO’s Seed Fund made its first investment of $200,000. TEDCO’s Seed Fund invests…

Continue Reading
August 7, 2019

BullFrog AI Signs Memorandum of Understanding with KBP Biosciences

BullFrog AI Innovative Artificial Intelligence Technology to Help Expand KBP’s Diverse Product Pipeline BALTIMORE – AUGUST 07, 2019 BullFrog AI specializes in helping pharmaceutical companies predict which patients will respond to…

Continue Reading
December 12, 2018

BullFrog AI Announces New Chief Technology Officer

BullFrog AI appoints seasoned executive to lead technology and development vision GAITHERSBURG, MARYLAND – BullFrog AI, Inc, a precision pharmaceutical company built around a powerful artificial intelligence (AI) platform, proudly…

Continue Reading
February 15, 2018

BullFrog AI Announces Strategic Partnership with The Lieber Institute for Brain Development to Improve Antipsychotic Drug Selection

Cutting-edge artificial intelligence platform to analyze antipsychotic drug use data from leading brain development institute to predict patient outcomes. WASHINGTON DC, and BALTIMORE, MD – Feb. 15th, 2018 ― BullFrog…

Continue Reading
October 20, 2017

Johns Hopkins Applied Physics Laboratory Licenses Big-Data Analysis Tool to BullFrog AI

The Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, has licensed a powerful data-analysis software tool — designed to discover patterns and relationships in large-scale and complex data —…

Continue Reading
October 17, 2017

BULLFROG AI LAUNCHES

Artificial Intelligence platform is making a difference in patient lives.

Continue Reading
October 17, 2017

Finding the Links that Can Save Lives

While reviewing some industry related headlines the other day, I came across this – “Eli Lilly and Co said its recently approved breast cancer drug failed to meet a late-stage…

Continue Reading

For media inquiries, please contact:

Liz Thibodeau
Thibodeau Media Group
Liz@thibmedia.com

Recent Articles

  • BullFrog AI and TTi Health Research & Economics Announce Partnership
  • BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development
  • BullFrog AI Secures $200K from TEDCO’s Seed Fund
  • BullFrog AI Signs Memorandum of Understanding with KBP Biosciences
  • BullFrog AI Announces New Chief Technology Officer

Archives

  • May 2020
  • April 2020
  • August 2019
  • December 2018
  • February 2018
  • October 2017

About BullFrog AI Holdings

Using the bfLeapTM Artificial Intelligence platform, BullFrog AI IP, a wholly owned subsidiary of Bullfrog AI Holdings that holds all of the intellectual property of the organization, specializes in helping pharmaceutical companies predict which patients will respond to therapies in development.

Contact

BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithersburg, MD 20878

info@bullfrogai.com

Google Tracking Code

Connect

© 2021 BullFrog AI Holdings. – Powered by DMVG Technology

    • Home
    • About
    • Our Technology
    • Our Solution
    • News/Press
    • Contact
    • Invest
    Our Crowdfunding Campaign Launched!

    Welcome.  If you’re interested in investing in us, check out our crowdfunding campaign here:

    https://invest.fundersusa.com/offering/bulbul/details

    NOTE: if you close this popup it won’t come back for 3 days.